相关实验视频
Updated: Jan 13, 2026

11:10
Hyperinsulinemic-euglycemic Clamps in Conscious, Unrestrained Mice
Published on: November 16, 2011
95.6K
儿童代谢障碍中的葡萄糖素:病理生理学和治疗前景
Giada Di Pietro1, Francesco Chiarelli1, Angelika Mohn1
1Department of Paediatrics, University G. d'Annunzio, 66100 Chieti, Italy.
Pediatric reports
|October 28, 2025
概括
葡萄糖不仅仅是一种反调节激素;它在糖尿病和肥胖等代谢障碍中发挥着关键作用. 了解葡萄糖的理解
科学领域:
- 内分泌学 在内分泌学.
- 代谢研究研究 代谢研究
- 分子生物学分子生物学
背景情况:
- 葡萄糖素作为胰岛素的逆调节激素的传统作用已经过时了.
- 新出现的证据强调了葡萄糖在代谢障碍病理生理学中的关键参与.
- 高葡萄糖血症在成人和儿科代谢疾病中普遍存在.
研究的目的:
- 为提供葡萄糖在代谢疾病中的病理生理学作用的全面审查.
- 综合最近关于葡萄糖在糖尿病,肥胖和NAFLD等疾病中的参与的发现.
- 探索新的治疗假设,通过准葡萄糖来管理代谢疾病.
主要方法:
- 文献综述和关于葡萄糖的当前研究的综合.
- 对将葡萄糖素与代谢障碍联系起来的病理生理机制的分析.
- 检查针对葡萄糖激素活动的治疗策略.
主要成果:
- 葡萄糖与糖尿病,肥胖和非酒精性脂肪肝疾病的发展和进展有关.
- 高血糖血是各种代谢条件中共同的特征.
- 旨在调节葡萄糖激素活性的治疗策略正在开发和应用中.
结论:
- 葡萄糖是一种重要的致病因子,也是代谢性疾病中的潜在治疗点.
- 对代谢性疾病管理和预防的新假设可以从了解葡萄糖的作用中得出.
- 向葡萄糖激素为成人和儿科代谢护理提供了有前途的途径.
相关概念视频
Hypoglycemia and Glucagon
822
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
822
Hormones Regulating Blood Glucose
6.4K
Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
In addition to accelerating glucose uptake and utilization, insulin has...
6.4K
Glucagon-like Receptor Agonists
836
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
836
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
2.2K
The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are...
Insulin and C-peptide are...
2.2K
Pathophysiology of Diabetes
3.1K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
3.1K
Pharmacokinetics in Pediatric Patients: Drug Metabolism
189
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
189

